I know how lobbyists make sure Americans don’t get dental care–I was one of them

Source: Fortune Date: November 19th, 2021 Author: Wendell Potter As Members of Congress continue their debate on the Build Back Better Act, it’s distressing to see House Democrats ignoring what Americans say they want most out of the legislation: adding dental coverage to Medicare. If the dental benefit isn’t put back into the bill, lawmakers will have shown once again that they listen more to two powerful trade groups in Washington–America’s Health Insurance Plans(AHIP) and the American Dental Association (ADA)–than to their constituents. As someone who has been on both sides, writing talking points for insurers and, more recently, fighting the ADA’s efforts to kill other bills to expand access to dental care, I know these organizations well. And they usually get their way. A recent Morning Consult poll found that the number one thing Americans say they want out of the reconciliation bill is Medicare dental coverage. That’s no surprise when you consider that millions of seniors lack dental coverage. Many suffer quietly with often excruciating pain caused by untreated–and often lethal–oral health disease. The main reason Medicare hasn’t covered dental care since its inception in 1965 (except when oral health problems become so severe they require hospitalization) is that organized dentistry staunchly opposed it. The dental lobby insists that any additional dental coverage should be restricted to the poorest Medicaid recipients. However, its main concern–as it was 56 years ago–is that Medicare would not reimburse dentists to their satisfaction. The ADA’s lobbyists, in essence, are placing the financial [...]

2021-12-21T12:29:10-07:00December, 2021|Oral Cancer News|

HPV vaccine gains support of ADA

Source: Multi Briefs Date: October 24th, 2018 Author: Tammy Adams The American Cancer Society estimates there will be more than 50,000 new cases of oral cancer in 2018. And between 70 to 80 percent of these cases will be attributed to the human papillomavirus virus (HPV), a virus that has types associated with oropharyngeal cancer. These staggering numbers call for action; action the American Dental Society is willing to take. Why? Because the HPV vaccine could prevent the vast majority of these new cases, but compared to other vaccines in the U.S., it is underutilized. According to a resolution passed recently by the ADA House of Delegates, the ADA urges dentists to support the use and administration of the human papillomavirus virus vaccine, recognizing it as a way to help prevent infection of the types of HPV associated with oropharyngeal cancer. Resolution 53H-2018 cites recommendations from the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices. It states that the vaccination is a "safe and effective intervention to decrease the burden of oral and oropharyngeal HPV infection." The policy is the result of a multifaceted ADA council proposal that includes input from the Council on Scientific Affairs, the Council on Advocacy for Access and Prevention and the Council on Dental Practice. A workgroup committed to the HPV issue and led by ADA volunteer members developed an evidence-based background report to help write the policy. Dr. Paul Eleazer, past chair of the ADA Council on Scientific Affairs, said that [...]

2018-10-25T15:38:39-07:00October, 2018|Oral Cancer News|

Dental groups dispute Consumer Reports cancer screening story

Source: http://www.drbicuspid.comBy:  Donna Domino, Features EditorDate: April 5, 2013   The dental community is up in arms over a recent Consumer Reports article that claims oral cancer screening is one of several medical tests that are overrecommended and unnecessary for all but high-risk patients. The article, which appears in the March 2013 issue, concluded that "most people shouldn't waste their time" on most diagnostic tests, including chairside visual screenings for oral cancer. "Most people don't need the test unless they are at high risk, because the cancer is relatively uncommon," Consumer Reports wrote. But the ADA and the Oral Cancer Foundation vehemently disagree with the magazine's conclusions, asserting that visual screening can result in earlier diagnosis of oral cancer and other oral diseases. The Consumer Reports article recommends only three cancer tests -- cervical, colon, and breast -- as worthwhile, and includes oral cancer screening among "eight to avoid" tests: ovarian, pancreatic, testicular, prostate, bladder, lung, oral cavity, and skin cancer. The magazine said its ratings were based mainly on reviews from the U.S. Preventive Services Task Force. Early diagnosis critical According to Consumer Reports, the medical community has "systematically exaggerated" the benefits of screening while downplaying the harms, such as unnecessary radiation and biopsies. The ADA quickly registered its disappointment with the recommendations and sent a letter -- co-signed by the American Academy of Oral & Maxillofacial Pathology -- to the editors of Consumer Reports, noting that noninvasive visual and tactile oral cancer screenings are typically included in oral exams [...]

2013-04-23T15:24:32-07:00April, 2013|OCF In The News, Oral Cancer News|

Ethics Being Questioned In Dentistry

Source: Dr.Bicuspid.com Scandals, lawsuits, a growing focus on commercialization and self-promotion, and dentists who prescribe excessive treatments are tarnishing the profession's image, according to a presentation on ethics at the recent ADA annual session in Las Vegas. Most dentists may be surprised that a Google search on ethical scandals among health professions shows that dentistry now gets more hits than medicine, nursing, chiropractics, and pharmacology, according to Ann Boyle, DMD, interim provost and vice chancellor for academic affairs at Southern Illinois University. Some of the public's changing perceptions toward dentistry can undoubtedly be traced to ubiquitous media coverage of scandals and malpractice lawsuits involving medical professionals, Dr. Boyle noted. Gordon Christensen, DDS, MSD, PhD, discussed the decline of dentists' credibility in a 2001 article, noting a Gallup poll showed that their ranking among professions had fallen below nurses, physicians, and veterinarians (Journal of the American Dental Association, August 2001, Vol. 132:8, pp. 1163-1165). Dentists were ranked third among the most trusted professionals in 1995 but slipped to ninth in 2001, according to Gallup poll rankings; they ranked sixth in 2009. Negative influences, according to Dr. Christensen, included commercialization and self-promotion, excessive treatment and fees, providing service only when it's convenient, and refusing to accept responsibility when treatment fails prematurely. “These front-line physicians consider us uncaring, selfish, greedy, and unprofessional.” — Ann Boyle, DMD, Southern Illinois University Dr. Boyle pointed to a 1997 Reader's Digest article about dentists' honesty. In it, the author visited 50 dentists in 28 states to see how [...]

Johnson & Johnson Sued for $70 Million Over Oral Cancer Test Detection

Source: Dr.Bicuspid.com July 8, 2011 -- Oral Cancer Prevention International (OCPI), makers of the Oral CDx brush test for oral cancer detection, is suing Johnson & Johnson (J&J) over a terminated distribution contract with OraPharma. OraPharma was previously a subsidiary of J&J until it was acquired last December by Water Street Healthcare Partners, a private equity firm in Chicago. J&J, which among other things sells Listerine mouthwash, was worried that a 2008 study linking alcohol-containing mouthwashes with oral cancer would negatively affect sales of Listerine and allegedly induced OraPharma to breach the sales agreement, according to OCPI. The lawsuit, filed July 6 in U.S. District Court, District of New Jersey, claims that J&J "maliciously and fraudulently" interfered with a contract between OCPI and OraPharma that gave OraPharma exclusive rights to sell the test to U.S. dentists. J&J's interference caused OraPharma "to suppress sales of and withhold from the public a proven lifesaving oral cancer prevention product in order to protect sales of its mouthwash, Listerine, which has been linked to oral cancer," according to the complaint. After OCPI signed the contract in February 2010, J&J did not want to "lend credence to the link between Listerine and oral cancer" by selling both its mouthwash and OralCDx, the complaint states. As of press time, J&J did not return calls for comment by DrBicuspid.com. Sales of Listerine bring in more than $1 billion per year, the suit claims. OralCDx is a "quick, painless, and inexpensive test that can prevent oral cancer by [...]

Oral cancer screenings a must, say malpractice attorneys

Source: Dr.Bicuspid.com By: Donna Domino March 10, 2011 -- The patient was insistent: All she wanted was to get her teeth whitened for an upcoming high school reunion. She came in for the $99 Internet special the dentist had run and mentioned a sore on her tongue, but she said it was recent, attributing it to a tongue-biting habit. The dentist did the procedure but advised the patient that she needed a follow-up oral exam. The patient eventually went to an oral surgeon who diagnosed the young mother with terminal tongue cancer. She sued the dentist who did the teeth whitening for malpractice, for missing her oral cancer. That case, Tale of the Tainted Tongue, was dramatized at the recent Chicago Dental Society Midwinter Meeting in a session highlighting the growing number of malpractice suits over missed oral cancer screenings. Anne Oldenburg, an attorney with Alholm, Monahan, Klauke, Hay & Oldenburg, which specializes in dental malpractice cases, participated in the mock trial. Ten years ago she didn't have many such cases, she told DrBicuspid.com. But that scenario has changed dramatically in recent years, she said, noting that she is currently involved in three dental malpractice cases. The mock trial was similar to a previous lawsuit she handled, in which a young man in his 40s died. "It was oral cancer that was clearly missed," Oldenburg recalled. The family settled for $750,000 because the children didn't want to go through the litigation process, but many death cases can reach $1 million [...]

Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue

Source: Clin Oral Investig. 2010 Apr 9 Authors: Rai B, Kaur J, Jacobs R, Anand SC. Tongue cancer is amongst the most common and fatal types of cancers in the world. The abnormalities in purine metabolism are characteristic features of many human tumors. Little is known about the correlation between the activities of key enzymes of purine nucleotide pathway and clinical indicators of tongue cancer invasiveness and aggressiveness. Fifty patients (M: F 25:25; mean age: 55.6 years (range 45-60; SD 1.8)) with diagnosed squamous cell carcinoma of the tongue (test group) and 30 normal subjects (M: F 15:15) without any systemic disease (control group) were recruited after obtaining informed consent. All patients were staged by the TNM classification. Salivary adenosine deaminase (ADA) activity was assessed in cancerous patients (test group) and normal healthy subjects (control group). Statistically significant differences between test and control groups were observed in salivary ADA (P

Go to Top